Convergent ablation for persistent atrial fibrillation: A UK multicentre perspective.
arrhythmia
atrial fibrillation
catheter ablation
hybrid ablation
Journal
Journal of cardiovascular electrophysiology
ISSN: 1540-8167
Titre abrégé: J Cardiovasc Electrophysiol
Pays: United States
ID NLM: 9010756
Informations de publication
Date de publication:
13 Aug 2024
13 Aug 2024
Historique:
revised:
23
07
2024
received:
14
03
2024
accepted:
30
07
2024
medline:
13
8
2024
pubmed:
13
8
2024
entrez:
13
8
2024
Statut:
aheadofprint
Résumé
Atrial fibrillation (AF) is the most common sustained arrhythmia worldwide and remains a major cause of morbidity and mortality. Unfortunately, a significant proportion of patients have persistent AF, for which conventional catheter ablation is less effective. However, convergent ablation has emerged in recent years as a hybrid treatment targeting both the epicardium and endocardium in a multidisciplinary joint cardiothoracic and electrophysiology procedure, with promising efficacy outcomes in recent studies. This treatment is increasingly being performed in the United Kingdom. This review article discusses the rationale and evidence behind convergent ablation, along with factors that need to be considered when setting up a successful ablation service.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 The Author(s). Journal of Cardiovascular Electrophysiology published by Wiley Periodicals LLC.
Références
Kornej J, Börschel CS, Benjamin EJ, Schnabel RB. Epidemiology of atrial fibrillation in the 21st century. Circ Res. 2020;127(1):4‐20.
Lippi G, Sanchis‐Gomar F, Cervellin G. Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge. Int J Stroke. 2021;16(2):217‐221.
Chugh SS, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study. Circulation. 2014;129(8):837‐847.
Hindricks G, Potpara T, Dagres N, et al. ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio‐Thoracic surgery (EACTS). Eur Heart J. 2020;42:2021.
Benjamin EJ, Muntner P, Alonso A, et al. Heart disease and stroke Statistics—2019 update: a report from the American Heart Association. Circulation. 2019;139(10):e56‐e528.
Davis RC, Hobbs FDR, Kenkre JE, et al. Prevalence of atrial fibrillation in the general population and in high‐risk groups: the ECHOES study. Europace. 2012;14(11):1553‐1559.
Hobbs F, Fitzmaurice D, Mant J, et al. A randomised controlled trial and cost‐effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. the SAFE study. Health Technol Assess (Rockv). 2005;9(40):1‐74.
Hagens VE, Ranchor AV, Van Sonderen E, et al Effect of rate or rhythm control on quality of life in persistent atrial fibrillation: results from the rate control versus electrical cardioversion (RACE) study. J Am Coll Cardiol. 2004;43(2):241‐247.
Packer DL, Kowal RC, Wheelan KR, et al Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic front (STOP AF) pivotal trial. J Am Coll Cardiol. 2013;61(16):1713‐1723.
Balk EM, Garlitski AC, ALSHEIKH‐ALI AA, Terasawa T, Chung M, Ip S. Predictors of atrial fibrillation recurrence after radiofrequency catheter ablation: a systematic review. J Cardiovasc Electrophysiol. 2010;21:1208‐1216.
Clarnette JA, Brooks AG, Mahajan R, et al. Outcomes of persistent and long‐standing persistent atrial fibrillation ablation: a systematic review and meta‐analysis. EP Europace. 2018;20(FI3):f366‐f376.
Zoni‐Berisso M, Lercari F, Carazza T, Domenicucci S. Epidemiology of atrial fbrillation: European perspective. Clin Epidemiol. 2014;6(1):213‐220.
Ganesan AN, Chew DP, Hartshorne T, et al. The impact of atrial fibrillation type on the risk of thromboembolism, mortality, and bleeding: a systematic review and meta‐analysis. Eur Heart J. 2016;37:1591‐1602.
Kiser AC, Landers M, Horton R, Hume A, Natale A, Gersak B. The convergent procedure: a multidisciplinary atrial fibrillation treatment. Heart Surg Forum. 2010;13(5):E317‐E321.
Wats K, Kiser A, Makati K, et al. The convergent atrial fibrillation ablation procedure: evolution of a multidisciplinary approach to atrial fibrillation management. Arrhythm Electrophysiol Rev. 2020;9(2):88‐96.
Mannakkara NN, Porter B, Child N, et al. Convergent ablation for persistent atrial fibrillation: outcomes from a single‐centre real‐world experience. Eur J Cardiothorac Surg. 2022;63(1):ezac515.
Delurgio DB, Crossen KJ, Gill J, et al Hybrid convergent procedure for the treatment of persistent and Long‐Standing persistent atrial fibrillation: results of CONVERGE clinical trial. Circ Arrhythm Electrophysiol. 2020;13:e009288.
Maclean E, Yap J, Saberwal B, et al. The convergent procedure versus catheter ablation alone in longstanding persistent atrial fibrillation: a single centre, propensity‐matched cohort study. Int J Cardiol. 2020;303:49‐53.
Larson J, Merchant FM, Patel A, et al Outcomes of convergent atrial fibrillation ablation with continuous rhythm monitoring. J. Cardiovasc Electrophysiol. 2020;31(6):1270‐1276.
Chung MK, Eckhardt LL, Chen LY, et al. Lifestyle and risk factor modification for reduction of atrial fibrillation: a scientific statement from the American heart association. Circulation. 2020;141:e750‐e772.
Middeldorp ME, Pathak RK, Meredith M, et al. PREVEntion and regReSsive effect of weight‐loss and risk factor modification on atrial fibrillation: the REVERSE‐AF study. EP Europace. 2018;20(12):1929‐1935.
Elliott AD, Verdicchio CV, Mahajan R, et al An exercise and physical activity program in patients with atrial fibrillatio: the ACTIVE‐AF randomized controlled trial. JACC Clin Electrophysiol. 2023;9(4):455‐465.
Al‐Khatib SM, Allen LaPointe NM, Chatterjee R, et al. Rate‐ and rhythm‐control therapies in patients with atrial fibrillation: a systematic review. Ann Intern Med. 2014;160:760.
Andrade JG, Deyell MW, Macle L, et al. Progression of atrial fibrillation after cryoablation or drug therapy. N Engl J Med. 2023;388(2):105‐116.
Wijffels MCEF, Kirchhof CJHJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation: a study in awake chronically instrumented goats. Circulation. 1995;92(7):1954‐1968.
Wazni OM, Dandamudi G, Sood N, et al. Cryoballoon ablation as initial therapy for atrial fibrillation. N Engl J Med. 2021;384(4):316‐324.
Rillig A, Magnussen C, Ozga AK, et al. Early rhythm control therapy in patients with atrial fibrillation and heart failure. Circulation. 2021;144:845‐858.
Kirchhof P, Camm AJ, Goette A, et al. Early rhythm‐control therapy in patients with atrial fibrillation. N Engl J Med. 2020;383(14):1305‐1316.
National Institute of Cardiovascular Outcomes Research (NICOR). National Audit of Cardiac Rhythm Management (NACRM) 2024 Summary Report (2022/23 data) [Internet]. Accesed June 4, 2024. https://www.nicor.org.uk/publications/ncap/cardiac-rhythm/2024/crm-final-report-2022-23?layout=default
Natale A, Reddy VY, Monir G, et al Paroxysmal AF catheter ablation with a contact force sensing catheter: results of the prospective, multicenter SMART‐AF trial. J Am Coll Cardiol. 2014;64(7):647‐656.
Bhargava M, Di Biase L, Mohanty P, et al. Impact of type of atrial fibrillation and repeat catheter ablation on long‐term freedom from atrial fibrillation: results from a multicenter study. Heart Rhyt. 2009;6(10):1403‐1412.
Haïssaguerre M, Jaïs P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998;339(10):659‐666.
Mont L, Bisbal F, Hernández‐Madrid A, et al. Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study). Eur Heart J. 2014;35(8):501‐507.
Tilz RR, Rillig A, Thum AM, et al Catheter ablation of long‐standing persistent atrial fibrillation: 5‐year outcomes of the hamburg sequential ablation strategy. J Am Coll Cardiol. 2012;60(19):1921‐1929.
Su WW, Reddy VY, Bhasin K, et al. Cryoballoon ablation of pulmonary veins for persistent atrial fibrillation: results from the multicenter STOP persistent AF trial. Heart Rhythm. 2020;17(11):1841‐1847.
Kessler Iglesias C, Pouliopoulos J, Thomas L, Hayward CS, Jabbour A, Fatkin D. Atrial cardiomyopathy: current and future imaging methods for assessment of atrial structure and function. Front Cardiovasc Med. 2023;10:1099625.
Verma A, Jiang CY, Betts TR, et al. Approaches to catheter ablation for persistent atrial fibrillation. N Engl J Med. 2015;372(19):1812‐1822.
Scherr D, Khairy P, Miyazaki S, et al. Five‐year outcome of catheter ablation of persistent atrial fibrillation using termination of atrial fibrillation as a procedural endpoint. Circ Arrhyth Electrophysiol. 2015;8(1):18‐24.
Haïssaguerre M, Hocini M, Sanders P, et al. Catheter ablation of long‐lasting persistent atrial fibrillation: clinical outcome and mechanisms of subsequent arrhythmias. J Cardiovasc Electrophysiol. 2005;16(11):1138‐1147.
Kistler PM, Chieng D, Sugumar H, et al. Effect of catheter ablation using pulmonary vein isolation with vs without posterior left atrial wall isolation on atrial arrhythmia recurrence in patients with persistent atrial fibrillation: the CAPLA randomized clinical trial. JAMA. 2023;329(2):127.
Kumar P, Mounsey JP. Atrial substrate modification for atrial fibrillation. Circ Arrhyth Electrophysiol. 2017;10(11):e005840.
Weimar T, Bailey MS, Watanabe Y, et al. The cox‐maze IV procedure for lone atrial fibrillation: a single center experience in 100 consecutive patients. J Interv Card Electrophysiol. 2011;31(1):47‐54.
Calkins H, Kuck KH, Cappato R, et al. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow‐up, definitions, endpoints, and research trial design. Heart Rhythm. 2012;9(4):632‐696.e21.
McClure GR, Belley‐Cote EP, Jaffer IH, et al. Surgical ablation of atrial fibrillation: A systematic review andmeta‐analysis of randomized controlled trials. EP Europace. 2018;20(9):1442‐1450.
Ad N, Holmes SD, Friehling T. Minimally invasive Stand‐Alone cox maze procedure for persistent and Long‐Standing persistent atrial fibrillation: perioperative safety and 5‐Year outcomes. Circ Arrhyth Electrophysiol. 2017;10(11):e005352.
Compier MG, Braun J, Tjon A, et al. Outcome of stand‐alone thoracoscopic epicardial left atrial posterior box isolation with bipolar radiofrequency energy for longstanding persistent atrial fibrillation. Neth Heart J. 2016;24(2):143‐151.
Geuzebroek GSC, Bentala M, Molhoek SG, Kelder JC, Schaap J, Van Putte BP. Totally thoracoscopic left atrial maze: standardized, effective and safe. Interact Cardiovasc Thorac Surg. 2016;22(3):259‐264.
Bulava A, Mokracek A, Hanis J, Kurfirst V, Eisenberger M, Pesl L. Sequential hybrid procedure for persistent atrial fibrillation. J Am Heart Assoc. 2015;4(3):e001754.
Muneretto C, Bisleri G, Rosati F, et al. European prospective multicentre study of hybrid thoracoscopic and transcatheter ablation of persistent atrial fibrillation: the HISTORIC‐AF trial. Eur J Cardiothorac Surg. 2017;52(4):740‐745.
Kiser AC, Landers MD, Boyce K, Sinkovec M, Pernat A, Geršak B. Simultaneous catheter and epicardial ablations enable a comprehensive atrial fibrillation procedure. Innovations Phila Pa. 2011;6(4):243‐247.
Kiser AC. Paracardioscopy provides endoscopic visualization of the heart. Innovations Phila Pa. 2009;4(4):233‐235.
Kiser AC, Cockfield W. Paracardioscopic ex‐maze procedure for atrial fibrillation. Multime Manual Cardioth Surg. 2010;2010(0201):2008.
DeLurgio DB, Ferguson E, Gill J, et al. Convergence of epicardial and endocardial RF ablation for the treatment of symptomatic persistent AF (CONVERGE Trial): rationale and design. Am Heart J. 2020;224:182‐191.
Makati KJ, Sherman AJ, Gerogiannis I, Sood N. Safety and efficacy of convergent hybrid procedure using cryo as endocardial energy source for the treatment of atrial fibrillation. Circ Arrhyth Electrophysiol. 2020;13:e008556.
Nakatani Y, Sakamoto T, Yamaguchi Y, Tsujino Y, Kinugawa K. Epicardial adipose tissue affects the efficacy of left atrial posterior wall isolation for persistent atrial fibrillation. J Arrhythm. 2020;36(4):652‐659.
Iso K, Okumura Y, Watanabe I, et al. Is vagal response during left atrial ganglionated plexi stimulation a normal phenomenon? Circ Arrhyth Electrophysiol. 2019;12(10):e007281.
Eranki A, Wilson‐Smith A, Flynn C, Williams M, Manganas C. Mid term freedom from atrial fibrillation following hybrid ablation, a systematic review and meta analysis. J Cardiothorac Surg. 2023;18:155.
Gehi AK, Paul Mounsey J, Pursell I, et al. Hybrid epicardial‐endocardial ablation using a pericardioscopic technique for the treatment of atrial fibrillation. Heart Rhythm. 2013;10(1):22‐28.
Civello KC, Smith CA, Boedefeld W Combined Endocardial and Epicardial Ablation for Symptomatic Atrial Fibrillation: Single Center Experience in 100+ Consecutive Patients Innovations in Cardiac Rhythm Management. J Innov Card Rhythm Manag. 2013;
Geršak B, Jan M. Long‐Term success for the convergent atrial fibrillation procedure: 4‐Year outcomes. Ann Thorac Surg. 2016;102(5):1550‐1557.
Zembala M, Filipiak K, Kowalski O, et al. Staged hybrid ablation for persistent and longstanding persistent atrial fibrillation effectively restores sinus rhythm in long‐term observation. Arch Med Sci. 2017;1(1):109‐117.
Kress DC, Erickson L, Choudhuri I, et al. Comparative effectiveness of hybrid ablation versus endocardial catheter ablation alone in patients with persistent atrial fibrillation. JACC Clin Electrophysiol. 2017;3(4):341‐349.
Gulkarov I, Wong B, Kowalski M, et al. Convergent ablation for persistent atrial fibrillation: single center experience. J Card Surg. 2019;34(10):1037‐1043.
Tonks R, Lantz G, Mahlow J, Hirsh J, Lee LS. Short and intermediate term outcomes of the convergent procedure: initial experience in a tertiary referral center. Ann Thorac Cardiovasc Surg. 2020;26(1):13‐21.
Carpenter A, Pannell LMK, Rizvi SIA, et al. Convergent approach to persistent atrial fibrillation ablation: long‐term single‐centre safety and efficacy. Front Cardiovasc Med. 2024;10:1336801.
Zembala M, Filipiak K, Kowalski O, et al. Minimally invasive hybrid ablation procedure for the treatment of persistent atrial fibrillation: one year results. Kardiol Pol. 2012;70(8):819‐828.
Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg. 1996;61:755‐759.
Di Biase L, Burkhardt JD, Mohanty P, et al. Left atrial appendage: an underrecognized trigger site of atrial fibrillation. Circulation. 2010;122(2):109‐118.
Tsai YC, Phan K, Munkholm‐larsen S, Tian DH, La meir M, Yan TD. Surgical left atrial appendage occlusion during cardiac surgery for patients with atrial fibrillation: a meta‐analysis. Eur J Cardiothorac Surg. 2015;47(5):847‐854.
Whitlock RP, Belley‐Cote EP, Paparella D, et al. Left atrial appendage occlusion during cardiac surgery to prevent stroke. N Engl J Med. 2021;384(22):2081‐2091.
Lakkireddy D, Sridhar Mahankali A, Kanmanthareddy A, et al. Left atrial appendage ligation and ablation for persistent atrial fibrillation. JACC Clin Electrophysiol. 2015;1(3):153‐160.
Lakkireddy DR, Wilber DJ, Mittal S, et al. Pulmonary vein isolation with or without left atrial appendage ligation in atrial fibrillation. JAMA. 2024;331(13):1099.
Gegechkori N, Yang F, Jacobowitz I, Greenberg Y. The effect of left atrial appendage closure on patients undergoing Hybrid/Convergent atrial fibrillation ablation. J Atrial Fibrillat Electrophysiol. 2022;15(4):66‐71.
Van Praet KM, Nersesian G, Kofler M, et al. Minimally invasive approach to the treatment of atrial fibrillation: concomitant convergent and LARIAT procedure. Multimed Man Cardiothorac Surg. 2022:2022. doi:10.1510/mmcts.2022.005
DeLurgio DB, Blauth C, Halkos ME, et al. Hybrid epicardial‐endocardial ablation for long‐standing persistent atrial fibrillation: A subanalysis of the CONVERGE Trial. Heart Rhythm O2. 2023;4(2):111‐118.
Eranki A, Wilson‐Smith AR, Williams ML, Flynn CD, Manganas C. Hybrid convergent ablation versus endocardial catheter ablation for atrial fibrillation: a systematic review and meta‐analysis of randomised control trials and propensity matched studies. J Cardiothorac Surg. 2022;17:181.
DeLurgio DB. Selection of patients for hybrid ablation procedure. J Cardiovasc Electrophysiol. 2023;34:2179‐2187.
Wijesuriya N, Papageorgiou N, MacLean E, Saberwal B, Ahsan S. The role of the electrophysiologist in convergent ablation. Arrhythm Electrophysiol Rev. 2020;9(1):8‐14.
Kress DC, Erickson L, Mengesha TW, Krum D, Sra J. Characterizing recurrence following hybrid ablation in patients with persistent atrial fibrillation. J Pati Cente Res Rev. 2020;7(3):227‐238.
Makati KJ, Sood N, Lee LS, et al. Combined epicardial and endocardial ablation for atrial fibrillation: best practices and guide to hybrid convergent procedures. Heart Rhythm. 2021;18(2):303‐312.
Ray S, Clarke SC. Getting it right first time (GIRFT): transforming cardiology care. Heart. 2022;109:344‐348.
NHS England. NHS England—Clinical Commissioning Policy: catheter ablation for paroxysmal and persistent atrial fibrillation (adults) [Internet]. 2022. Accesed July 22, 2024. https://www.england.nhs.uk/wp-content/uploads/2022/12/1903-Clinical-Commissioning-Policy-Catheter-ablation-paroxysmal-persistent-atrial-fibrillation.pdf
Anderson LH, Black EJ, Civello KC, Martinson MS, Kress DC. Cost‐effectiveness of the convergent procedure and catheter ablation for non‐paroxysmal atrial fibrillation. J Med Econom. 2014;17(7):481‐491.
AtriCure Inc. clinicaltrials.gov. CONVERGE Post‐Approval Study (PAS). Accessed May 19, 2023. https://clinicaltrials.gov/ct2/show/NCT05393180
Leung LWM, Toor P, Akhtar Z, et al. Real‐world results of oesophageal protection from a temperature control device during left atrial ablation. Europace. 2023;25(5):euad099.
Leung LWM, Bajpai A, Zuberi Z, et al. Randomized comparison of oesophageal protection with a temperature control device: results of the IMPACT study. EP Europace. 2021;23(2):205‐215.
Kueffer T, Tanner H, Madaffari A, et al. Posterior wall ablation by pulsed‐field ablation: procedural safety, efficacy, and findings on redo procedures. Europace. 2023;26(1):euae006.
Conti S, Sabatino F, Fortunato F, Ferrara G, Cascino A, Sgarito G. High‐Power Short‐Duration lesion Index‐Guided posterior wall isolation beyond pulmonary vein isolation for persistent atrial fibrillation. J Clin Med. 2023;12(16):5228.
Kaba R. clinicaltrials.gov. Hybrid AbLaTion of Atrial Fibrillation (HALT‐AF). 2022. Accessed May 19, 2023. https://clinicaltrials.gov/ct2/show/NCT05411614